Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Genzyme is not calling its newest MS drug a 'cure', but it looks like one in most patients
Genzyme is not calling its newest MS drug a 'cure', but it looks like one in most patients
Genzyme is not calling its newest MS drug a 'cure', but it looks like one in most patients
Submitted by
admin
on October 8, 2015 - 9:10am
Source:
Bizjournals.com
News Tags:
Genzyme
MS
Lemtrada
multiple sclerosis
Headline:
Genzyme is not calling its newest MS drug a 'cure', but it looks like one in most patients
Do Not Allow Advertisers to Use My Personal information
